Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Issam Moussa

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
Journal of the American College of Cardiology|October 23, 2012
A contemporary view of diagnostic cardiac catheterization and percutaneous coronary intervention in the United States: a report from the CathPCI Registry of the National Cardiovascular Data Registry, 2010 through June 2011Gregory J Dehmer, Douglas Weaver, Matthew T Roe, et al.
The Journal of Invasive Cardiology|July 30, 2004
Comparison of safety and efficacy between first and second generation of angio-seal closure devices in interventional patientsZoran Lasic, Roxana Mehran, George Dangas, et al.
The American Journal of Cardiology|July 20, 2002
Effect of catheter-based iridium-192 gamma brachytherapy on the added risk of restenosis from diabetes mellitus after intervention for in-stent restenosis (subanalysis of the GAMMA I Randomized Trial)Jeffrey W Moses, Issam Moussa, Martin B Leon, et al.
International Journal of Cardiovascular Interventions|March 8, 2003
Coronary stent implantation throughout technical evolution: immediate and follow-up resultsLeo Finci, Massimo Ferraro, Yoshio Kobayashi, et al.
The New England Journal of Medicine|January 26, 2017
Registry-Based Prospective, Active Surveillance of Medical-Device SafetyFrederic S Resnic, Arjun Majithia, Danica Marinac-Dabic, et al.
The American Journal of Cardiology|October 29, 2005
Impact of coronary culprit lesion calcium in patients undergoing paclitaxel-eluting stent implantation (a TAXUS-IV sub study)Issam Moussa, Stephen G Ellis, Michael Jones, et al.
The American Journal of Cardiology|July 31, 2003
Long-term follow-up of patients after gamma intracoronary brachytherapy failure (from GAMMA-I, GAMMA-II, and SCRIPPS-III)Thosaphol Limpijankit, Roxana Mehran, Gary S Mintz, et al.
Circulation|May 5, 2004
Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudyIssam Moussa, Martin B Leon, Donald S Baim, et al.
Kidney International|January 28, 2005
Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventionsEugenia Nikolsky, Roxana Mehran, Zoran Lasic, et al.
The American Journal of Cardiology|December 28, 2004
Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variablesGeorge Dangas, Ioannis Iakovou, Eugenia Nikolsky, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Journal of the American College of Cardiology|October 23, 2012
A contemporary view of diagnostic cardiac catheterization and percutaneous coronary intervention in the United States: a report from the CathPCI Registry of the National Cardiovascular Data Registry, 2010 through June 2011Gregory J Dehmer, Douglas Weaver, Matthew T Roe, et al.
The Journal of Invasive Cardiology|July 30, 2004
Comparison of safety and efficacy between first and second generation of angio-seal closure devices in interventional patientsZoran Lasic, Roxana Mehran, George Dangas, et al.
The American Journal of Cardiology|July 20, 2002
Effect of catheter-based iridium-192 gamma brachytherapy on the added risk of restenosis from diabetes mellitus after intervention for in-stent restenosis (subanalysis of the GAMMA I Randomized Trial)Jeffrey W Moses, Issam Moussa, Martin B Leon, et al.
International Journal of Cardiovascular Interventions|March 8, 2003
Coronary stent implantation throughout technical evolution: immediate and follow-up resultsLeo Finci, Massimo Ferraro, Yoshio Kobayashi, et al.
The New England Journal of Medicine|January 26, 2017
Registry-Based Prospective, Active Surveillance of Medical-Device SafetyFrederic S Resnic, Arjun Majithia, Danica Marinac-Dabic, et al.
The American Journal of Cardiology|October 29, 2005
Impact of coronary culprit lesion calcium in patients undergoing paclitaxel-eluting stent implantation (a TAXUS-IV sub study)Issam Moussa, Stephen G Ellis, Michael Jones, et al.
The American Journal of Cardiology|July 31, 2003
Long-term follow-up of patients after gamma intracoronary brachytherapy failure (from GAMMA-I, GAMMA-II, and SCRIPPS-III)Thosaphol Limpijankit, Roxana Mehran, Gary S Mintz, et al.
Circulation|May 5, 2004
Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudyIssam Moussa, Martin B Leon, Donald S Baim, et al.
Kidney International|January 28, 2005
Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventionsEugenia Nikolsky, Roxana Mehran, Zoran Lasic, et al.
The American Journal of Cardiology|December 28, 2004
Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variablesGeorge Dangas, Ioannis Iakovou, Eugenia Nikolsky, et al.
Pageof 8